The organ that is most affected by multiple myeloma is sometimes your kidneys.
Although multiple myeloma mainly affects your bone marrow and bones but it can also affect other organs and most particularly the kidneys.
The abnormal plasma cells in multiple myeloma interfere with your normal bone marrow function and cause bone damage and can also lead to kidney problems.
Multiple myeloma cells grow in your bone marrow and result in destruction of the bones also called osteolytic lesions and osteoporosis and it can result in bone pain, fractures and spinal cord compression and it can also affect the spine, skull, ribs and pelvis.
Your bone marrow is the main site of myeloma cell proliferation and it interferes with the production of healthy blood cells, which lead to anemia and increased susceptibility to infection.
And the abnormal proteins that are produced by myeloma cells can also damage your kidneys and result in kidney problems and even kidney failure and is often a result of buildup of the proteins in the kidneys.
Multiple myeloma is a type of cancer which starts in your plasma cells.
The cancer associated with multiple myeloma starts in your plasma cells that are a type of white blood cells that are found in your bone marrow.
The white blood cells normally produce antibodies to fight off infections, but with multiple myeloma, the white blood cells grow out of control and can form tumors, that are often in your bone marrow.
When the plasma cells become cancerous, they are then called myeloma cells and the cells grow uncontrollably and accumulate in your bone marrow.
Multiple Myeloma refers to the presence of multiple tumors or myelomas in your bone marrow and if there is only one plasma cell tumor, it is called a solitary plasmacytoma.
The symptoms of multiple myeloma are unexplained weight loss, frequent infections, fatigue, mental fogginess or confusion, loss of appetite, constipation, nausea and bone pain that occurs mostly in the spine or chest.
The life expectancy of someone with multiple myeloma ranges from as low as 29 months to as long as 62 months depending on how far advanced the multiple myeloma is.
You can live 20 years and sometimes longer with multiple myeloma.
However some people may live much longer than the life expectancy of multiple myeloma.
The median length of survival after diagnosis with multiple myeloma is 62 months for Stage I, 44 months for Stage II, and 29 months for Stage III.
Life expectancy depends on many factors, including the person's age, health, kidney function, and more.
There have been some people who have lived 20 years and a bit longer when they've been diagnosed with multiple myeloma.
The 10 year survival rate for multiple myeloma is 30%.
When people have multiple myeloma they have around a 30 percent survival rate with the multiple myeloma but with treatment you can usually increase your survival rate.
The first symptoms and signs of multiple myeloma usually include bone pain, spine and chest pain and even nausea.
Although sometimes people have multiple myeloma without any signs or symptoms.
Some people can have multiple myeloma for months or years before they even know they're sick with the disease.
This earliest phase of multiple myeloma is called smoldering multiple myeloma.
When you have it, you won't have any symptoms, but your test results will show: At least 10% to 59% of your bone marrow is made up of cancerous plasma cells.
If you don't treat multiple myeloma the multiple myeloma will progress and spread further and eventually kill you.
Although multiple myeloma still comes back it's a good idea to treat the multiple myeloma to prevent it from spreading and killing you too quickly.
With treatment you can live a little longer with the multiple myeloma.
A person can get multiple myeloma by and from exposure to toxic chemicals, atomic radiation, anything that interferes with the immune system, or infection with cancer-causing viruses have all been implicated as causes or triggers of myeloma.
Toxic chemicals that have been identified include: benzene. dioxins (such as those found in Agent Orange)
The people who are most likely to get multiple myeloma are people of ages 65 and above although some people younger and as young as age 35 get multiple myeloma.
Also if you have a history of cancer in your family then you're at an increased risk of developing multiple myeloma.
The disease and cancer multiple myeloma is a fatal disease.
Even with treatment the multiple myeloma can come back and still be fatal.
Multiple myeloma is not curable although chemotherapy and other medicines are available to help kill off the multiple myeloma cancer but it usually comes back which is why it's not fully curable.
There's no way to cure multiple myeloma naturally or any other way.
There are however some approved medicines that can be taken to help slow the progression of multiple myeloma.
Typical treatment for multiple myeloma includes chemotherapy, a common therapy to kill cancerous cells.
Other multiple myeloma treatments include bisphosphonates which are drugs used to strengthen bones in arthritis patients.
There's no cure as of now for multiple myeloma but treatments can help and help prevent the multiple myeloma from progressing.
Multiple Myeloma is a terminal cancer as there's no full on cure for it as of now.
However treatments can help prevent and slow the progression of the multiple myeloma cancer.
Myeloma is a relapsing-remitting cancer.
Multiple Myeloma is not always a death sentence since treatments are available to help prevent the spread of the disease.
Multiple Myeloma is a form of Leukemia of plasma cells.
Myeloma is a tumor of the bone marrow, and involves a specific subset of white blood cells that produce a distinctive protein.
Leukemia can arise in either of two main groups of white blood cell types -lymphocytes or myelocytes.
Multiple Myeloma is considered a rare disease and rare cancer.
The Multiple Myeloma is more common in males than it is in females.
Multiple myeloma is a rare type of deadly cancer that is slightly more common in males than females.
Over 32,000 individuals in the United States were diagnosed with multiple myeloma in 2019.
It is also believed that approximately 100,000 Americans currently have the multiple myeloma disease.
Multiple myeloma is considered a cancer of plasma cells, and non-Hodgkin lymphoma is a cancer of lymphocytes.
WM cells have features of both plasma cells and lymphocytes.
WM cells make large amounts of a certain type of antibody (immunoglobulin M, or IgM), which is known as a macroglobulin.
Multiple myeloma is classified by stage 1, 2, or 3. In multiple myeloma cases, stage 3 is the terminal stage.
This means it's the most advanced stage of this type of rare cancer.
Doctors use the international staging system to determine the stage of the cancer.
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell.
Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs.
In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells.
Multiple myeloma is an uncommon cancer of the blood.
The median length of survival after diagnosis with multiple myeloma is 62 months for Stage I, 44 months for Stage II, and 29 months for Stage III.
Life expectancy depends on many factors, including the person's age, health, kidney function, and more.
Currently, there are also no obvious, strong risk factors for myeloma.
Although the mutations that cause myeloma are acquired and not inherited, family history is a known risk factor for multiple myeloma.
First-degree relatives of people with multiple myeloma have a 2 to 3 times higher risk of developing the disease.